157 related articles for article (PubMed ID: 11496858)
1. Antiretroviral therapy for previously treated patients.
Montaner JS; Mellors JW
N Engl J Med; 2001 Aug; 345(6):452-5. PubMed ID: 11496858
[No Abstract] [Full Text] [Related]
2. Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
Albrecht MA; Bosch RJ; Hammer SM; Liou SH; Kessler H; Para MF; Eron J; Valdez H; Dehlinger M; Katzenstein DA;
N Engl J Med; 2001 Aug; 345(6):398-407. PubMed ID: 11496850
[TBL] [Abstract][Full Text] [Related]
3. Choosing the best initial therapy for HIV-1 infection.
Clumeck N
N Engl J Med; 1999 Dec; 341(25):1925-6. PubMed ID: 10601514
[No Abstract] [Full Text] [Related]
4. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.
Starr SE; Fletcher CV; Spector SA; Yong FH; Fenton T; Brundage RC; Manion D; Ruiz N; Gersten M; Becker M; McNamara J; Mofenson LM; Purdue L; Siminski S; Graham B; Kornhauser DM; Fiske W; Vincent C; Lischner HW; Dankner WM; Flynn PM
N Engl J Med; 1999 Dec; 341(25):1874-81. PubMed ID: 10601506
[TBL] [Abstract][Full Text] [Related]
5. Performance of a quadruple combination including nelfinavir plus efavirenz in naive subjects with high baseline viral load and in patients failing protease inhibitor-containing regimens.
Barreiro P; Oller V; Soriano V; Nuñez M; Rodríguez-Rosado R; González-Lahoz J
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):391-2. PubMed ID: 11317086
[No Abstract] [Full Text] [Related]
6. Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
Martínez E; Arnaiz JA; Podzamczer D; Dalmau D; Ribera E; Domingo P; Knobel H; Riera M; Pedrol E; Force L; Llibre JM; Segura F; Richart C; Cortés C; Javaloyas M; Aranda M; Cruceta A; de Lazzari E; Gatell JM;
N Engl J Med; 2003 Sep; 349(11):1036-46. PubMed ID: 12968087
[TBL] [Abstract][Full Text] [Related]
7. Simplification of protease inhibitor-containing regimens with efavirenz, nevirapine or abacavir: safety and efficacy outcomes.
Chiesa E; Bini T; Adorni F; Capetti A; Rizzardini G; Faggion I; Mussini C; Sollima S; Melzi S; Bongiovanni M; Tordato F; Cicconi P; Castelnuovo B; Rusconi S; d'Arminio Monforte A
Antivir Ther; 2003 Feb; 8(1):27-35. PubMed ID: 12713061
[TBL] [Abstract][Full Text] [Related]
8. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
[No Abstract] [Full Text] [Related]
9. Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected children.
Spector SA; Hsia K; Yong FH; Cabral S; Fenton T; Fletcher CV; McNamara J; Mofenson LM; Starr SE
J Infect Dis; 2000 Dec; 182(6):1769-73. PubMed ID: 11069252
[TBL] [Abstract][Full Text] [Related]
10. Combination study for children.
Vazquez E
Posit Aware; 1998; 9(1):15. PubMed ID: 11364991
[TBL] [Abstract][Full Text] [Related]
11. The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV-1-infected patients with undetectable plasma viral load.
Bickel M; Rickerts V; Stephan C; Jacobi V; Rottmann C; Dauer B; Carlebach A; Thalhammer A; Miller V; Staszweski S
HIV Med; 2005 May; 6(3):179-84. PubMed ID: 15876284
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy in the experienced patient.
Gallant JE
Hopkins HIV Rep; 1999 Mar; 11(2):1, 4, 9, 16. PubMed ID: 11366245
[TBL] [Abstract][Full Text] [Related]
13. Efavirenz in HIV infection.
Casado JL; Moreno S
N Engl J Med; 2000 Apr; 342(17):1290-1. PubMed ID: 10787332
[No Abstract] [Full Text] [Related]
14. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
[TBL] [Abstract][Full Text] [Related]
15. DMP 266 and indinavir combination.
AIDS Patient Care STDS; 1997 Aug; 11(4):287-8. PubMed ID: 11361845
[No Abstract] [Full Text] [Related]
16. [HIV infections: mortality reduced only in developed countries].
Wehr A
Dtsch Med Wochenschr; 1999 May; 124(18):A8-9. PubMed ID: 10356577
[No Abstract] [Full Text] [Related]
17. Protease inhibitor failure trial: combination 1592, 141W94, and efavirenz.
AIDS Treat News; 1997 Dec; (No 284):4. PubMed ID: 11364914
[TBL] [Abstract][Full Text] [Related]
18. Virologic response of nine therapy-experienced children receiving 64 weeks of nelfinavir salvage therapy.
Vavro CL; Zimmermann AM; McClernon DR; Kehne SL; Martel LA; Valentine ME; McKinney RE
Ann N Y Acad Sci; 2000 Nov; 918():381-5. PubMed ID: 11131731
[No Abstract] [Full Text] [Related]
19. Persistence of human immunodeficiency virus (HIV) type 1 DNA in peripheral blood despite prolonged suppression of plasma HIV-1 RNA in children.
Saitoh A; Hsia K; Fenton T; Powell CA; Christopherson C; Fletcher CV; Starr SE; Spector SA
J Infect Dis; 2002 May; 185(10):1409-16. PubMed ID: 11992275
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of abacavir plus efavirenz as a salvage regimen in HIV-infected individuals after 48 weeks.
Wasmuth JC; Herhaus C; Römer K; Salzberger B; Kaiser R; Schliefer K; Voigt E; Rockstroh JK
AIDS; 2002 May; 16(7):1077-8. PubMed ID: 11953478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
